Voyager Therapeutics (VYGR) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.59
-0.45
-0.3
-0.16

Details

Expected EPS
-0.448673
Actual EPS
-0.53
Surprise EPS
-0.08
Surprise Percent
-18.13%

Description

⁨Voyager Therapeutics⁩ (⁦VYGR⁩) has reported earnings of ⁦-0.53⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts